Each Group member (marketing authorization holder) operates a pharmacovigilance unit that maintains its PV system and supports patients during product use. By collecting, analyzing, and evaluating safety data, potential risks are identified early and appropriate risk-control measures are taken to reduce adverse reaction risk. Sihuan maintains a professional pharmacovigilance team whose members hold medical or pharmaceutical backgrounds and specialized PV knowledge, responsible for systematic monitoring and risk management across all products.